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ABSTRACT 
EFFECT OF CAMEL MILK ON PLASMA LIPIDS PROFILE AND 
GLUCOSE LEVEL IN INDUCED-HYPERCHOLESTEROLEMIC AND 
HYPERGLYCEMIC RATS (Rattus narvegicus) 
 
Nahed Zen Elabedin Idam 
 
M. Sc. (Biochemistry) 
 
The present study was carried out to investigate the effect of oral 
administration of raw camel milk on the level of plasma lipids profile and 
glucose concentration in induced hypercholesterolemic and 
hyperglycemic rats respectively by conducting two experiments. 
In the first experiment twenty one male rats were divided into 
three groups namely A, B and C, of 7 rats each. Group A was used as a 
control group and was given normal diet, group B received a diet 
containing 1% cholesterol and group C received a diet containing 1% 
cholesterol in addition to 16 ml/kg body weight (Bwt) of raw camel milk 
given orally twice daily for four weeks. 
 There was a significant (P<0.05) increase in the levels of plasma 
total cholesterol (TC), low density lipoprotein – cholesterol (LDL-c) and 
triglycerides (TG) in group B compared to the control group. There was 
insignificant decrease in the level of plasma total cholesterol, LDL-c and 
triglycerides in group C compared to the control. However, there was no 
significant difference between groups B and C in the level of plasma TC, 
LDL-c and TG despite the decrease in group C. The levels of plasma 
 viii
HDL-c was significantly (P<0.05) lower in group B and C compared to 
the control group. 
In the second experiment eighteen male rats were divided into 
three groups namely A, B and C, of 6 rats each. Normal plasma glucose 
was measured after an overnight fast (18 h.). Group A was used as a 
control group and was given 10 ml/kg Bwt distilled water orally 
simultaneously with 2 gm/kg Bwt of 50% sterile glucose solution 
intraperitoneally, group B was given 10 mg/kg Bwt glibenclamide orally 
simultaneously with 2 gm/kg Bwt of 50% sterile glucose solution 
intraperitoneally and group C was given 16 ml/kg Bwt raw camel milk 
orally simultaneously with 2 gm/kg Bwt of 50% sterile glucose solution 
intraperitoneally. The plasma glucose level was monitored after 1, 2 and 
4 hours following treatment.  
The results revealed that, plasma glucose concentration was 
significantly (P<0.05) decreased after 2 and 4 hours in group B and C 
compared to the control group. However, after 2 hours following 
treatment the decrease in the plasma glucose concentration was more in 
group B compared to group C. 
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 1
INTRODUCTION 
  
Camel milk is a very important nutrient source for human in 
several arid and semi-arid zones of subtropical and tropical regions 
where it represents often the only protein source (Farah, 1996). 
Traditionally the most common forms of consumption are either fresh or 
fermented milk (Mehaia et al., 1995 and Farah et al., 2007). Camel milk 
is generally opaque white, it has sweet and sharp taste, but sometimes its 
taste is salty and it differs from other ruminant milk having low sugar, 
low cholesterol, high minerals (Knoess, 1979) and high amount of 
vitamin C (Knoess, 1977; Sawaya et al., 1984; Mehaia, 1994). 
In addition to the nutritive value camel milk was subjected to 
many different studies which deal with its therapeutic effect (Elagamy et 
al., 1996; Wernery; 2003; Agrawal et al., 2004; Majieed., 2005). The 
therapeutic effect of camel milk may be due to the fact that camel 
browses from different herbs and shrubs (Yagil, 1982). Agrawal et al. 
(2004) reported that raw camel milk has hypoglycemic effect.   
Various reports indicated the role of camel milk in the health of 
human and its medicinal value (Yagil, 1982; Yagil   et al., 1994; Singh, 
2001; Wernery 2003). In this sense, Yagil et al. (1994) and Elagamy      
et al. (1996) revealed the higher antimicrobial activity of raw camel milk.  
        With the increase of the awareness about camel milk in health of 
human and since the effect of raw camel milk on plasma total cholesterol 
and its fractions was not scientifically studied in Sudan, and because of 
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the high amount of vitamin C in camel milk (Farah et al., 1992) and its 
role as an antioxidant (Agrawal et al., 2004). Therefore, the present study 
was carried out to investigate the effect of raw camel milk on plasma 
total cholesterol and its fractions. Also glucose will be measured in 
hyperglycemic rats in an attempt to establish more rational uses of raw 
camel milk to decrease the incident of atherosclerosis and lowering blood 
glucose level. The parameters to be investigated include the following: 
• Plasma total cholesterol.  
• LDL-cholesterol.  
• HDL-cholesterol. 
• Triglycerides. 
• Plasma glucose.  
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CHAPTER ONE 
LITERATURE REVIEW 
1.1 Chemical composition of camel milk 
       Camel milk is characterized by a well balanced composition suitable 
for human consumption. The average composition of dromedary camel 
milk reported in the literature from various parts in the world showed a 
wide range of variations in the chemical composition (Gnan and sheriha, 
1986). This could be greatly due to several factors such as breeds, 
nutrition, environment and age (Yagil and Etzion, 1980, Falah, 1997). 
Also the stage of lactation has similar effect (EL – Badawi, 2004). The 
mean values for chemical composition of camel milk are slightly lower 
than that of cow milk, whereas, the ash content is relatively higher than 
that of cow milk (Sawaya et al., 1984; Abu-Lehia, 1987; Elamin and 
Wilcox, 1992; Mehaia, 1994). Camel milk is produced as a mixture of 
fat, protein, lactose, minerals, vitamins, and its constituents dispersed in 
water (Schwartz and Dioli, 1992). The later forms the major part of milk.  
1.1.1 Fat content of camel milk 
  The concentration of fat in camel milk varies from 1.9% to 5.6% 
(Bayoumi, 1990; Mehaia, 1995; Nabag, 2004; El-Badawi, 2004; Jebreel, 
2006). Depending on the breed and feeding condition, the average being 
the same as for cow milk. Further chemical study revealed that camel 
milk contained high amount of polyunsaturated fatty acids especially 
linoleic and linolenic acids which are essential for human nutrition 
compared with cow milk. Since poly-unsaturated fatty acids may lower 
human serum lipids, hence they lead to decrease incidence of lipids 
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related cardiovascular disease (Gorban and Izzeldin, 2001).  Also they 
reported a high content of medium chain fatty acids in camel milk. 
1.1.2 Protein content of camel milk 
         The concentration of total protein in camel milk was found to range 
from 2.0% to 5.5% (Knoess, 1977; Sawaya et al., 1984; Farah, 1993; 
Nabag, 2004). In the Sudan, El-Badawi (2004) reported that camel milk 
protein is 3.2%. Similarly Jebreel (2006) revealed that the concentration 
of protein in Sudanese camel milk is 3.0%. The total protein of camel 
milk is composed of several specific proteins. Casein and whey protein 
are the major groups of total protein and the average values of casein and 
whey protein vary from 1.9 to 2.3% and 0.7 to 1.0% respectively 
(Mehaia, 1987; Farah, 1993; El-Badawi, 2004).The main components of 
whey proteins in camel milk were similar to that in bovine milk, except 
the lack of beta-lactoglobulin, a major serum protein found in other 
livestock ruminants milk (El-Hatmi et al., 2007; Merin et al., 2001). In 
this regard, camel milk could be more suitable to be used as a substitute 
of human milk in infant diet and for alleviating some allergic reactions, 
especially in children (Shabo et al., 2005).  
1.1.3 Other proteins component of camel milk 
         Camel milk is a rich source of protein with potential antimicrobial 
and protective activities (Wernery, 2003). The most important one is 
lysozyme, which inhibits the growth of pathogenic bacteria more than 
cow milk (Elagamy et al., 1992). The concentration of lysozyme, 
lactoferrin and immunoglobulin in camel milk is 1.32 µg/ml, 0.17mg/ml 
and 2.227 mg/ml respectively, which is higher than cow milk which 
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contains 0.273 µg/ml, 0.0767 mg/ml and 0.520 mg/ml respectively. 
Camel milk contains high amount of novel peptidoglycan recognition 
protein, which have broad antimicrobial activity and stimulate the 
immune system, this protein was not found or found in minor amount in 
cow milk (Wernery, 2003). Other proteins which have been identified in 
camel milk include serum albumin, beta lactalbumin, immunoglobulins 
and whey basic protein or lactophorin (Kappeler et al., 2004). Singh 
(2001) reported that camel milk contained high amount of insulin like 
protein (52 unit/litre). Moreover, camel milk constitutes a valuable 
source of lactoperoxidase enzyme (Elagamy et al., 1992). 
1.1.4 Vitamins content of camel milk  
         Camel milk is an important source of vitamin C which is three 
times higher than that of bovine milk (Sawaya et al., 1984; Farah et al., 
1992). They found that vitamin C ranged from 25 - 60 mg/l and 26 - 61 
mg/l respectively. Moreover the amount of niacin was higher in camel 
milk than that of cow milk which ranged from 4 - 6 mg/kg and 0.5 – 0.8 
mg/kg respectively. Conversely, the level of folic acid in camel milk is 
less than cow milk which is about 0.04 mg/kg and 0.01 – 1.0 mg/kg 
respectively (Sawaya et al., 1984; Farah, 1993). According to Sawaya     
et al. (1984) camel milk contains lower amount of vitamin A compared 
to cow milk which is about 0.15 mg/kg of camel milk and 0.17- 0.38 
mg/kg of cow milk and very trace amount of vitamin B12. Farah et al. 
(1992) reported that camel milk contains the same amount of vitamin E 
as cow milk which ranges from 0.21 – 0.91 mg/l.  
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1.1.5 Medicinal value of camel milk 
  Several studies demonstrated the values of camel milk and its 
healthiness (Rao et al., 1970; Yagil, 1987). Nomadic belief on camel 
milk, accordingly, they used it either fresh or fermented milk and for 
different reasons. Camel milk was reported to have medicinal value 
(Attia et al., 2001; Sarwar, 2002) and it is used in some part of the world 
as a cure for certain diseases (Knoess, 1982). Rao et al. (1970) reported 
that camel milk was used as a therapy for dropsy, jaundice, problem of 
spleen, tuberculosis, asthma and anemia. Yagil (1982) mentioned that 
camel milk was given to the sick, elderly and very young people because 
it works in bone formation. Also he indicated that camel milk has health 
properties that all the bacteria are driven from the body. This action of 
camel milk may put less pressure on the immune system which in turn 
may improve the other function of the body. Moreover camel milk works 
as a laxative for people unaccustomed to drink it (Roa et al., 1970). 
Several studies demonstrated the ability of camel milk to inhibit the 
growth of pathogenic bacteria through the high content of protective 
protein (Al-Nakil, 1984; Sallam, 1991; Farah, 1993; Elagamy et al., 
1996). A series of auto- immune diseases can be treated by camel milk 
(Wernery, 2003).  Magieed (2005) reported that camel milk is effective 
against toxicity and carcinogenicity of aflatoxin.                               
           Agrawal et al. (2004) investigated the hypoglycemic effect of raw 
camel milk in diabetic rats. He found that treatment of rats with (25 ml of 
camel milk daily) instead of water for three weeks resulted in a 
significant decrease in blood glucose level compared to the control 
group.  Yagil et al. (1994) and Singh (2001) found significant amount of 
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insulin like protein in camel milk and its effect on blood sugar was 
studied. Agrawal et al. (2003) claimed that camel milk acts as adjunct to 
insulin therapy and efficacious in improving long term glycemia as it 
helps in the reduction of insulin doses in type-1 diabetic patients due to 
the effect of insulin like protein which is found in camel milk.  
1.2 Cholesterol 
         Cholesterol is an amphipathic lipid and indispensable structure and 
metabolic component of all animal cells, present in tissues and plasma 
lipoprotein in the form of free cholesterol or combined with long- chain 
fatty acid as cholesteryl ester which is the storage form of cholesterol. 
The cholesterol pool of the body is derived from absorption of dietary 
cholesterol and de - novo synthesis, primarily in the liver and intestine. It 
is synthesized in many tissues from acetyl Co-A through complex 
pathway and directly regulated by the cholesterol present and ultimately 
eliminated from the body in the bile as cholesterol or bile salts. 
Cholesterol performs many important roles in the body despite the bad 
publicity associated with it. It is the precursor of other all steroids in the 
body such as corticosteroids, sex hormones, bile acids and vitamin D 
(Murray et al., 1999). Cholesterol is required to maintain cell membrane 
and regulate membrane fluidity over a wide range of temperature (Smith, 
1991). Recently, cholesterol has also been implicated in cell signalling 
process and reducing the permeability of the plasma membrane to 
hydrogen and sodium ions (Haines, 2001). Cholesterol is insoluble in the 
blood but transported in a shell of phospholipids and special protein 
called apolipoprotein forming a family of lipid protein particles or 
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lipoprotein. Epidemiological data demonstrated that the risk of coronary 
heart disease and other forms of atherosclerotic vascular disease rises 
with plasma cholesterol concentration (Davidson, 2002). Changes in the 
diet play an important role in reducing plasma cholesterol.                                                 
1.2.1   Types of cholesterol 
1.2.1.1 High density lipoprotein - cholesterol (HDL-c) 
            HDL-c is one of the lipoproteins family, it is rich in cholesterol 
and has low triglycerides content. It is synthesized in liver and to a lesser 
extent in the intestine. HDL-c has unique function of serving as a 
reservoir for ApoE and ApoC-II and regulates the exchange of protein 
and various lipoproteins in the blood. Another critical function of HDL-c 
is participation in the removal of the excess and harmful cholesterol from 
peripheral tissue through the action of plasma enzyme lecithin – acyl - 
transferase (LACT) and transports it to the liver for elimination from the 
body by the way of biliary system and feces as cholesterol and bile salts. 
This process termed ''reverse cholesterol transport''. There is an inverse 
relationship  between  plasma HDL-c concentration and incidence of 
coronary artery disease (Devlin, 2002).                                                                                
1.2.1.2 Low density lipoprotein-cholesterol (LDL-c)   
           Most of the cholesterol contained in the blood plasma is present in 
low density lipoprotein which is the main vehicle for carrying cholesterol 
to the peripheral tissues and for this reason called ''bad cholesterol''. 
LDL-c is formed in the plasma from very low density lipoprotein and 
about half of circulating LDL-c is taken up by the liver and the remainder 
is taken by the high affinity LDL-receptors which bind apoB-100. 
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However some LDL-c uptake occurs without the intervention of receptor. 
The number of receptors is down regulated by the cholesterol 
requirement in the body (Montgomery et al., 1990). A positive 
correlation between the incidence of atherosclerosis and concentration of 
LDL-c which is appears to be harmless until oxidized by free radicals. 
Since the oxidized form is easily retained by macrophages (Teissedre et 
al., 1996). 
1.3 Triacylglycerols (TG) 
       Triacylglycerols are the most significant and the major form of lipid 
in the body. They are transported between tissues in lipoproteins and are 
stored as an energy reserve in adipose tissues. Triacylglycerol may be 
provided by diet or may be synthesized from non-lipid source largely in 
the liver, adipose tissue and lactating mammary glands (Swenson and 
Reece, 1993). Catabolism of these compounds by lipoprotein lipase 
enzyme supply the body with essential fatty acids in addition to the 
important useful energy in animals (Murray et al., 1999). Defective 
lipoprotein lipolysis results in hypertriglyceridaemia which is associated 
with low circulating HDL-c level. A much weaker correlation also exists 
between plasma triacylglycerols concentration and atherosclerosis 
(Davidson, 2002).  
1.4 Diseases associated with elevated level of plasma cholesterol 
1.4.1 Atherosclerosis 
         Atherosclerosis is a progressive inflammatory disorder of arterial 
wall that is characterized by the deposition of cholesterol and cholesterol 
ester of lipoproteins containing Apo B-100 in connective tissues of the 
 10
arterial walls which leads to the formation of fatty fibrous plaque that 
narrow the lumen of arteries and may lead to thrombosis. Atherosclerosis 
correlates with a high plasma LDL-c: HDL-c ratio, clinically it remains 
silent until became large enough to impair arterial perfusion (Davidson, 
2002). Complication of atherosclerosis could be diminished and life be 
prolonged when plasma cholesterol lowered by hypocholesterolemic 
agents (Frick et al., 1987). 
1.4.2 Coronary heart disease 
          Coronary heart disease (CHD) is the most common form of heart 
disease and it is almost always due to atheroma and its complication 
resulting from inadequate blood flow. It continues to be the leading cause 
of death in industrialized nations. CHD rises with high plasma LDL-c 
concentration which carries the most of the circulating plasma 
cholesterol. Additional factors beside high cholesterol level considered to 
play a part in coronary heart disease include high pressure, smoking, and 
obesity. High level of scavenger HDL-c is thought to be anti-atherogenic, 
consistent with the observation that raised levels reduced the risk of CHD 
(Davidson, 2002).  
1.5 Factors reducing the incidence of atherosclerosis 
1.5.1 Vitamins supplementation in the diet 
1.5.1.1 Vitamin C (Ascorbic acid)      
             Vitamin C is a water soluble vitamin, it is required for the 
synthesis of carnitine and stimulate plasma lipoprotein lipase enzyme 
which is required in the catabolism of triglycerides and involved in the 
catabolism of cholesterol to bile salts (Simon and Hudes 2000). Several 
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studies demonstrated that supplementation of vitamins C in the diet 
reduced the risk of heart disease.  Khoja and Marzouki (1994) reported 
that the administration of 5 mg/day of vitamin C to hypercholesterolemic 
rats for 7 weeks decreased the level of plasma total cholesterol and 
triglycerides and increase the level of plasma HDL-c. The 
hypocholesterolemic activity of vitamin C is due to enhancement of the 
activity of the cholesterol -7α-hydroxylase enzyme which involves in the 
catabolism of cholesterol. Kilic (1993) reported that administration of 
vitamin C (0.5 g/100ml of water for 6 weeks) to rats decreased the level 
of liver and plasma total cholesterol.  
1.5.1.2 Vitamin E (Tocopherol) 
                  Vitamin E is the fat soluble vitamin act as an essential part in 
protecting plasma lipoproteins against oxidative modification and 
inhibits 3-hydroxy-3-methylglutaryl co-A reductase enzyme (HMGcoA), 
the rate limiting enzyme in cholesterol biosynthesis (Sebely et al., 2003).       
            Prasad and Kalra (1993) investigated the effect of high 
cholesterol diet in the presence of vitamin E on lipids profile in rabbit 
when added to the normal diet. They found that vitamin E increased 
HDL-c and decreased LDL-c and triglycerides. Al-Juary et al. (2006) 
demonstrated that incorporation of vitamin E (50 mg/kg) to rats normal 
diet significantly decreased plasma total cholesterol, LDL-c and 
triglycerides without significant changes in plasma HDL-c. Khoja and 
Marzouki (1994) reported that administration of 5 gm/kg vitamin E to the 
rats diet containing (0.5% cholesterol) decreased the level of plasma total 
cholesterol and triglycerides and increased HDL-c level.  
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1.5.2 Inhibitors of 3-hydroxy-3-methylglutaryl-coA reductase 
enzyme (HMG-CoA)  
               HMG-coA inhibiters are a group of prescribed drugs used to lower 
cholesterol by reducing HMG-CoA enzyme which is the rate limiting 
enzyme of the mevalonate pathway of cholesterol synthesis. Inhibition of 
this enzyme in the liver stimulates LDL-c receptors resulting in an 
increased clearance of LDL-c (Davidson, 2002). 
        Several clinical prevention trials have firmly established that 
normalization of elevated serum cholesterol levels by HMG-CoA 
reductase inhibitors reduces the incidence of coronary events (Maher and 
Thompson, 1990). HMG-CoA reductase inhibitors may play more 
important role in reducing hypercholesterolemia (Fujita and Matsushima, 
1999).  
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CHAPTER TWO 
MATERIAL AND METHODS 
 
2.1 Materials and Design 
      Two experiments were designed to investigate the effect of raw 
camel (Camelus dromedarius) milk on the levels of plasma lipids profile 
and glucose in induced hypercholesterolemic and hyperglycemic Wistar 
albino rats, respectively. 
2.1.1 Experimental Animals 
   Twenty one male Wistar albino rats weighing 85–120g and 
eighteen male rats weighing 150-200g were used for experiment (1) and 
(2) respectively. They were obtained from Faculty of Pharmacy, 
University of Khartoum. The animals were housed in the premises of the 
Medical and Aromatic Plants Research Institute in stainless – steel cages 
and kept under suitable environmental conditions. All rats were fed with 
standard diet and acclimatized for seven days before starting the 
experiment. 
2.1.2 Feeding Program 
    The rats were fed with defined diet mixture called standard diet to 
cover rat’s requirement, which was obtained from the National Center for 
Research, Khartoum. The diet ingredients include the following: 
Wheat flour              65.7% 
Meat                        22% 
Oil                           12% 
Sodium chloride     0.3%  
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2.1.3 Experiment (1) 
This experiment was performed to investigate the effect of raw camel 
milk on the levels of plasma lipids profile in induced hypercholesterolemic 
Wistar albino rats. 
2.1.3.1 Cholesterol supplementation in the rat diet 
  Cholesterol was supplemented as 1% cholesterol powder to the 
rats standard diet so as to induce hypercholesterolemia according to Son 
et al. (2003), with exception of the control group. 
2.1.3.2 Equipment 
- Pipettes. 
- Centrifuge. 
- Haematocrit capillaries. 
- Lithium heparin and plane containers. 
- The roche diagnostic/Hitachi 902 analyzer. 
2.1.3.3 Chemicals 
- Cholesterol powder. (LAB TECH chemicals). 
     -    Lithium heparin. 
2.1.3.4 Experimental procedure 
   The rats were divided randomly into three groups A, B and C each 
of seven rats, having an average body weight of 120 g, each was put in a 
separate cage. Group A was fed standard diet and used as untreated 
control. Group B received a diet containing 1% cholesterol only, while 
group C received a diet containing1% cholesterol in addition to 16 ml/kg 
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body weight (Bwt) of raw camel milk twice daily, given orally via a 
gastric tube. Duration of the experiment was four weeks. 
2.1.4 Experiment (2) 
        This experiment was performed to elucidate the effect of raw camel 
milk on the plasma glucose concentration in induced hyperglycemic 
Wistar albino rats employing glucose tolerance test (GTT).  
2.1.4.1 Equipment used 
        -   Pipettes. 
        -  Centrifuge. 
        -   Fluoride oxalate containers. 
   -  The roche diagnostic/Hitachi 902 analyzer. 
   -   Capillary tubes. 
2.1.4.2 Chemicals 
         -  Glucose solution 50%. 
         -  Halothane. 
2.1.4.3 Glucose tolerance test procedure 
            The rats were divided into three groups A, B and C each of six 
rats. After an over – night fast the plasma glucose was estimated, then all 
three groups of rats were injected with 2 gm/kg Bwt of 50% sterile 
glucose solution intraperitoneally according to Murali el al. (2004). 
Immediately after glucose injection, rats in group A were given 10 ml/kg 
Bwt of distilled water (D.W) and used as control group, group B was 
given orally 10 mg/kg Bwt of glibenclamide (a hypoglycemic drug) 
according to Dimo et al. (2006), while rats in group C were given orally 
16 ml/kg Bwt of raw camel milk.  
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2.1.5 Blood samples collection method 
       For experiment (1) blood samples were collected every two weeks 
interval during the experimental period, after an over- night fast (12 
hours). Blood was drawn from the orbital plexus by capillary glass tube 
according to the method of Nagappa et al. (2003) and collected in lithium 
heparin containers. Then the blood was centrifuged for 10 min. at 5000 
rpm for the separation of plasma. Thereafter, plasma was stored frozen 
until used for the analysis of total cholesterol, HDL-c, LDL-c and 
triglycerides.  
           For experiment (2) blood samples were collected in fluorinated 
test tubes from the orbital plexus under inhalation anesthesia using 
halothane and glucose level was estimated at 1, 2 and 4 hours following 
injection. 
2.2 Analytical Methods 
      All parameters were measured in Research and Laboratory Unit, 
Khartoum Teaching Hospital by using roche diagnostic/Hitachi 902. 
2.2.1 The Roche Diagnostic/Hitachi 902 System 
         The RD analyzer is used to report test result on various body 
fluids including serum, plasma, urine and other samples for a wide range 
of analyses. It is fully automated, discrete, computerized and performed 
potentiometric and photometric assays. The apparatus consists of 
photometric measuring system, analytical processing unit, LCD touch 
screen and printer. The analyzer is characterized by its ability to perform 
200 tests photometrically per hour. 
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2.2.2 Plasma total cholesterol determination 
Principle: 
        In this method the concentration of total cholesterol is determined by 
using single reagent in three coupled reactions. 
Cholesterol ester + H2O    cholesterol esterase   cholesterol + fatty acid  
Cholesterol + O2      cholesterol oxidase       cholestenone + H2O2 
2H2O2 +   phenol + aminoantipyrine      Peroxidase       Quinoneimine + 4H2O 
Reagents: 
- Good buffer (pH 6.7). 
- Phenol. 
- 4-amino antipyrine. 
- Cholesterol Esterase. 
- Cholesterol oxidase. 
- Peroxidase. 
2.2.3 Plasma high density lipoprotein – cholesterol determination           
Principle 
  HDL-c was measured by using direct method which consists of 
two steps: 
1) First elimination of Chylomicron, LDL-c and VLDL-c by using 
cholesterol oxidase and cholesterol esterase. 
2) In the second step HDL-c released by using detergent in reagent 
(2) and therefore making it available for quantitation. The intensity 
of color reflects the HDL-c concentration. 
 Cholesterol ester + H2O   cholesterol esterase              cholesterol + fatty acid  
 Cholesterol + O2             cholesterol oxidase        cholestenone + H2O2 
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H2O2 + N-Ethyl, N (2- hydroxy-3-sulfopropyl)-3, 5-Dimethoxy-4-Flouroaniline            
peroxidase   blue colored complex + H2O 
The intensity of the quinineimine dye produced is directly 
proportional to the HDL-c concentration. 
Reagents:  
Reagent 1: 
- Good buffer (pH 7). 
- 4-amino antipyrine. 
- Peroxidase. 
- Ascorbate oxidase. 
Reagent 2: 
- Good buffer. 
- Cholesterol esterase. 
- Peroxidase. 
- Cholesterol oxidase. 
- N–Ethyl–N (2–hydroxy–3-sulfoporpyl)–3, 5–Dimethoxy–4–
flouro aniline (F–DAOS). 
2.2.4 Plasma low density lipoprotein-cholesterol determination 
Principle: 
  Non LDL-c lipoproteins are enzymetically processed while LDL-c 
is selectively protected by reagent (R1). Then LDL-c is released under the 
action of reagent (R2) and selectively determined. 
LDL-c + H2O       cholesterol esterase     cholesterol + fatty acid 
Cholesterol + O2   cholesterol oxidase      cholestenone +  H2O2 
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H2O2+ 4–aminoantipyrine + N–(2–Hydroxy–3–sulfopropyl)–3, 5–
dimethoxy aniline    peroxidase    blue colored complex. 
Reagent 1: 
- Good buffer (pH 6.8). 
- Cholesterol oxidase. 
- Cholesterol esterase. 
- N–(2–hydroxy–3sulfoporpyl)–3,5–Dimethoxy aniline (H–DAOS) 
Reagent 2: 
- Good buffer (pH 7). 
- 4-amino antipyrine. 
- Peroxidase. 
- Sodium azide. 
2.2.5 Plasma triglycerides determination 
Principle: 
 Determination of plasma triglycerides begins after enzymatic 
splitting with lipoprotein lipase. Indicator is quinoneimine which is 
generated under the catalytic action of peroxidase 
Triglyceride    lipoprotein lipase    glycerol + fatty acid  
Glycerol + ATP    Glycerol kinase    glycerol–3–phosphate + ADP 
Glycerol-3-phosphate + O2  Glycerol–3–Phosphate oxidase  
Dihydroxy acetone phosphate + H2O2 
2H2O2 + amino antipyrine + 4 –chlorophenol    peroxidase    
    Quinoneimine  + HCl +4 H2O     
Reagents:  
-  Good buffer. 
- 4 – chlorophenol  
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- Magnesium. 
- Glycerol kinase. 
- Peroxidase. 
- Lipoprotein lipase. 
- 4 –amino antipyrine. 
- Glycerol 3 – phosphate oxidase. 
- ATP. 
2.2.6 Plasma glucose determination  
Principle: 
  In the presence of glucose oxidase, glucose is oxidized to gluconic 
acid and hydrogen peroxide. The later reacts in the presence of 
peroxidase with phenol and 4–aminophenozone to form quinoneimine 
dye. The    intensity of color is proportion to glucose concentration. 
D – glucose + H2O + O2   glucose oxidase      D – gluconic acid + H2O2 
H2O2 + 4 – aminophenazone + phenol   peroxidase   quinoneimine + H2O 
Reagents: 
- Phenol. 
- Phosphate buffer (PH 7.5). 
- 4–amino antipyrine. 
- Glucose oxidase. 
- Peroxidase. 
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2.3 Statistical analysis 
  The experimental data were analyzed by employing complete 
randomized design to separate the means and standard error with the aid 
of (SPSS) using computer program. The means separation was calculated 
by using another computer package program (SAS). 
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CHAPTER THREE 
RESULTS 
  
3.1 The effect of raw camel milk on the levels of plasma total 
cholesterol, HDL-c, LDL-c and triglycerides in induced 
hypercholesterolemic Wistar albino rats. 
3.1.1 Total cholesterol (TC) 
 The results of plasma total cholesterol level of groups A, B and C 
are presented in Table (1) and Fig. (1).    
There is a significant increase (P<0.05) in plasma total cholesterol 
level in group B (cholesterol fed untreated group) and group C 
(cholesterol fed treated group) compared to the control group (Group A) 
which received standard diet only. However, the increase is more in 
group B compared to group C with no significant difference. 
3.1.2 High density lipoprotein-cholesterol (HDL-c) 
The results of plasma HDL-c level of groups A, B and C are 
presented in Table (1) and Fig. (2). 
The plasma HDL-c level is significantly (P<0.05) lower in group B 
and group C compared to the control group. However, the level of HDL-
c is non - significantly higher in group C compared to group B. 
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Table (1): The effect of raw camel milk on plasma total cholesterol, 
LDL-c, HDL-c and triglycerides in induced-
hypercholesterolemic Wistar albino rats.   
                                                                                                                                             
 
Means (± SE) within the same row having different superscript small letters 
are significantly different at (P<0.05). 
                                      
        Group A: Fed standard diet.   
Group B: Fed standard diet with 1% cholesterol.                                                 
Group C: Fed standard diet with 1% cholesterol and given orally 16 ml/kg Bwt 
raw camel milk.                           
             
 
 
 
 
 
 
C 
 
B 
 
A 
  Groups 
  
Parameters       
134.52 ±14.84a 150.00 ± 15.49a81.76 ± 1.98b 
Total cholesterol     
     (mg/dl)   
34.79 ± 1.87b 33.30 ± 1.44b 47.77 ± 1.83a 
HDL-c 
(mg/dl) 
82.63 ± 13.12a 107.40 ± 14.78a27.65 ± 1.80b LDL-c (mg/dl) 
90.48 ± 4.87a 93.95 ± 6.66a 73.29 ± 5.47b Triglycerides  (mg/dl) 
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Fig. (1): The effect of raw camel milk on plasma total cholesterol 
level in induced-hypercholesterolemic Wistar albino rats.                           
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 Bars having different superscript small letters are significantly different at 
(P<0.05). 
  
   
Group A: Fed standard diet. 
Group B: Fed standard diet with 1% cholesterol. 
Group C: Fed standard diet with 1% cholesterol and given orally       
16 ml/kg Bwt raw camel milk. 
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 Fig. (2): The effect of raw camel milk on plasma HDL-c level in 
induced-hypercholesterolemic Wistar albino rats.      
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Bars having different superscript small letters are significantly different at 
(P<0.05). 
 
Group A: Fed standard diet. 
Group B: Fed standard diet with 1% cholesterol. 
Group C: Fed standard diet with 1% cholesterol and given orally       
16 ml/kg Bwt raw camel milk. 
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3.1.3 Low density lipoprotein-cholesterol (LDL-c) 
          The results of plasma LDL-c of groups A, B and C are presented in 
Table (1) and Fig. (3). 
        The level of plasma LDL-c is significantly (P<0.05) higher in group 
B and group C compared to the control group. In group C the level of 
LDL-c is non - significantly lower compared to group B. 
3.1.4 Triglycerides (TG) 
      The results of plasma triglycerides of groups A, B and C are 
presented in Table (1) and Fig. (4). 
     The result showed that the level of plasma triglycerides is 
significantly (P<0.05) higher in groups B and C compared to the control 
group. While there is no significant difference between group C and 
group B despite the lower level of triglycerides in group C. 
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Fig. (3): The effect of raw camel milk on plasma LDL-c level in 
induced-hypercholesterolemic Wistar albino rats. 
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Fig. (4): The effect of raw camel milk on  plasma triglycerides in 
induced-hypercholesterolemic Wistar albino rats.          
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3.2 The effect of raw camel milk on plasma glucose concentration in 
induced hyperglycemic Wistar albino rats 
The results of plasma glucose concentration of group A, B and C 
are presented in Table (2) and Fig. (5).    
        The level of plasma glucose is significantly (P<0.05) higher in all 
the groups after one hour following glucose administration compared to 
time zero (fasting level). 
The control group (Group A) which was injected with only glucose 
showed a significant (P<0.05) increase in plasma glucose level after one 
hour compared to the pretreatment level. Then gradual decrease occurred 
and after four hours following treatment the plasma glucose level was 
still higher than the pretreatment level. 
Group B which was given glucose simultaneously with 
glibenclamide drug showed a significant (P<0.05) increase in plasma 
glucose level after one hour following treatment compared to the 
pretreatment level and after two and four hours following treatment the 
level of plasma glucose is decreased significantly (P<0.05) compared to 
one hour. However, the level of blood glucose after four hour is non - 
significantly (P<0.05) different compared to time zero. 
In group C which was given glucose simultaneously with raw 
camel milk the increase in plasma glucose level is significantly (P<0.05) 
higher after one hour following treatment compared to the pretreatment 
level. While after two hours following treatment the level of plasma  
glucose  is  significantly  (P<0.05)  lower  compared  to  the  level  at one 
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Table (2): The effect of raw camel milk on plasma glucose 
concentration in induced-hyperglycemic Wistar albino 
rats. 
                                         
Means (±SE) within the same row having different superscript small 
letters are significantly different at (P<0.05). 
Means (±SE) within the same column having different superscript capital 
letters are significantly different at (P<0.05). 
Group A: injected with glucose at a dose of 2 gm/kg Bwt 
intraperitoneally (IP). 
Group B: injected with glucose at a dose of 2 gm/kg Bwt (IP) and given 
orally 10 mg/kg Bwt glibenclamide. 
Group C: injected with glucose at a dose of 2 gm/kg Bwt (IP) and given 
orally 16 ml/kg Bwt raw camel milk.                                     
             
 
 
 
 
 
 
Glucose (mg/dl) following injection       Parameter 
Groups 
Fasting 
one hour Two hours Four hours 
A 82.33±1.23dA 146.00±2.13aA 130.00±2.13bA 103.33±1.74cA 
B 86.00±1.24cA 142.67±2.601aA 106.17±3.38bC 82.83±0.79c B 
C 84.00±1.24cA 144.33±2.50aA 114.17±2.90bB 86.17±1.19c B 
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hour. However, after four hours following treatment the plasma glucose 
level is non- significantly different compared to time zero. 
The different treated groups were compared to the control group 
which showed typical performance of glucose tolerance test (GTT) with 
considerable increase and gradual decrease toward the fasting level.  
In group B the level of plasma glucose after fasting and one hour is 
non - significantly different compared to the control group. However the 
level of plasma glucose after two and four hours is significantly (P<0.05) 
lower compared to the control group. 
In group C the level of plasma glucose after fasting and one hour is 
non-significantly different compared to the control group.  However, the 
level of plasma glucose after two and four hours is significantly (P<0.05) 
lower compared to the control group.   
There is no significant difference (P<0.05) between the treated 
groups (B and C) after fasting, one and four hours. The blood glucose 
level after two hour is significantly (P< 0.05) lower in group B compared 
to group C. 
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Fig. (5): The effect of raw camel milk on plasma glucose concentration   
in induced-hyperglycemic Wistar albino rats. 
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Group A: Injected with glucose at a dose of 2 gm/kg Bwt 
intraperitoneally (IP). 
Group B: Injected with glucose at a dose of 2 gm/kg Bwt (IP) and 10 
mg/kg Bwt glibenclamide. 
Group C: Injected with glucose at a dose of 2 gm/kg Bwt (IP) and 
given orally 16 ml/kg raw camel milk. 
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CHAPTER FOUR 
DISCUSSION 
         There is an increasing global concern about the role of the food in 
health and disease. The concept is consistent with historic belief that 
natural substances play an important role in prevention and treatment. 
Camel milk is of putative hypocholesterolemic and hypoglycaemic effect 
in Sudanese traditional medicine (personal communication, 2007). 
Therefore, the present study aims to evaluate the effect of raw camel milk 
nutrients on the levels of plasma lipids profile and glucose concentration 
in induced hypercholesterolemic and hyperglycemic rats.  
         Experiment (1) was conducted to study the effect of raw camel milk 
on the levels of plasma lipids profile in induced hypercholesterolemic rats. 
In this experiment hypercholesterolemia was induced in rats by feeding 
1% cholesterol enriched diet which caused a remarkable increase of 
plasma total cholesterol and triglycerides. The study showed that 
administration of 16 ml/kg Bwt of raw camel milk twice daily caused 
insignificant decrease in the levels of plasma total cholesterol, LDL-c, and 
triglycerides compared to the control group. This decrease corresponds to 
(10.32%), (23.06%) and (3.69%) for total cholesterol, LDL-c and 
triglycerides respectively in comparison with cholesterol fed untreated 
group. The results revealed that there was a significant (P<0.05) decrease 
in the levels of plasma HDL-c in camel milk treated group compared to 
the control group.  These findings are in line with Agrawal et al. (2003) 
who reported that the oral administration of 500 ml of raw camel milk for 
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three months did not significantly affect the levels of plasma lipid profiles 
of type one diabetic patients. Similar result was found by Mahamad et al. 
(2006) who reported that camel milk have no significant effect on the 
serum lipids profile at 500 ml/kg Bwt when it was given to type 1 diabetic 
patients for 4 weeks. The effect of camel milk on cholesterol is attributed 
to vitamin C content which acts as antioxidant (Agrawal et al., 2004). The 
insignificant effect reported in this study may be due to the fact that 
vitamin C which is found in camel milk is not quite enough to decrease 
the plasma cholesterol level.   
         In contrast Elayan et al. (2008) found hypocholesterolemic effect of 
fermented camel milk (gariss) in diet- induced hypercholesterolemic rats. 
They reported that supplementation of 0.5 g gariss for 6 weeks reduced 
the level of plasma total cholesterol, LDL-c and triglyceride with no 
significant effect on HDL-c. Suzuki et al. (1991) reported that fermented 
dairy product have been recommended as dietary supplement because of 
their hypocholesterolemic effect. The source of variation may be due to 
the fact that fermented milk contains more hypocholesterolemic factors 
greater than milk (Eichholzer and Stahelin, 1993).   
         Experiment (2) was performed to investigate the effect of raw 
camel milk in achieving glycemic control in comparison to glibenclamide 
(a hypoglycaemic drug) in glucose loaded rats. The results obtained 
indicated that the oral administration of raw camel milk simultaneously 
with glucose to rats resulted in a significant decrease of plasma glucose 
concentration compared to the control group. This result is in agreement 
with Agrawal et al. (2004) who investigated the effect of raw camel milk 
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on streptozotocin induced diabetic rats. They found that there was a 
significant decrease in blood glucose concentration in rats received 250 
ml of camel raw milk for three weeks. It has been found that the 
hypoglycaemic effect of raw camel milk is presumed to be due to 
presence of insulin like protein (Singh, 2001) which increased the uptake 
of glucose by cells, providing the same biological activity as insulin 
itself.  Beg et al. (1986) reported that the amino acid sequence of some 
protein of camel milk has superficial similarity to insulin peptides. 
Wangoh (1993) reported that the therapeutic efficacy of raw camel milk 
is due to the lack of coagulum formation in the stomach which allows the 
camel milk to pass rapidly together with insulin like protein and remain 
available for absorption. 
         Furthermore, the result showed that the hypoglycaemic effect of 
camel milk was significantly (P<0.05) lower when compared to the 
commonly used hypoglycaemic drug glibenclamide. This is due to the 
fact that the drug stimulates insulin secretion from pancreatic beta-cells 
and increases the sensitivity of peripheral tissue to insulin (Rang and 
Dale, 1991). 
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CONCLUSION 
          The results of the current study concluded that raw camel milk has 
no beneficial effect on plasma lipid profiles. The study also demonstrated 
that the raw camel milk possesses hypoglycemic activity and this finding 
has important implication in clinical management.  
         Further comparative investigations are required using different 
doses and for longer time, which may be more helpful in establishing 
wide uses of camel milk.  
        Further studies are required to show the effect of camel milk 
insulin like protein on type one diabetes mellitus. 
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